2-190998211-A-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_007315.4(STAT1):​c.633+6T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00435 in 1,610,038 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0032 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0045 ( 24 hom. )

Consequence

STAT1
NM_007315.4 splice_region, intron

Scores

2
Splicing: ADA: 0.001653
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.194
Variant links:
Genes affected
STAT1 (HGNC:11362): (signal transducer and activator of transcription 1) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-190998211-A-T is Benign according to our data. Variant chr2-190998211-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 333289.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1, Benign=2}. Variant chr2-190998211-A-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00324 (494/152336) while in subpopulation NFE AF = 0.00516 (351/68028). AF 95% confidence interval is 0.00471. There are 2 homozygotes in GnomAd4. There are 230 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAT1NM_007315.4 linkc.633+6T>A splice_region_variant, intron_variant Intron 8 of 24 ENST00000361099.8 NP_009330.1 P42224-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAT1ENST00000361099.8 linkc.633+6T>A splice_region_variant, intron_variant Intron 8 of 24 1 NM_007315.4 ENSP00000354394.4 P42224-1

Frequencies

GnomAD3 genomes
AF:
0.00325
AC:
494
AN:
152218
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000869
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00452
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00516
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00307
AC:
772
AN:
251186
AF XY:
0.00298
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00280
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00149
Gnomad NFE exome
AF:
0.00491
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00447
AC:
6515
AN:
1457702
Hom.:
24
Cov.:
30
AF XY:
0.00440
AC XY:
3190
AN XY:
725486
show subpopulations
Gnomad4 AFR exome
AF:
0.000987
AC:
33
AN:
33420
Gnomad4 AMR exome
AF:
0.00262
AC:
117
AN:
44722
Gnomad4 ASJ exome
AF:
0.00287
AC:
75
AN:
26096
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39646
Gnomad4 SAS exome
AF:
0.000638
AC:
55
AN:
86164
Gnomad4 FIN exome
AF:
0.00160
AC:
85
AN:
53164
Gnomad4 NFE exome
AF:
0.00537
AC:
5953
AN:
1108480
Gnomad4 Remaining exome
AF:
0.00319
AC:
192
AN:
60264
Heterozygous variant carriers
0
307
613
920
1226
1533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00324
AC:
494
AN:
152336
Hom.:
2
Cov.:
32
AF XY:
0.00309
AC XY:
230
AN XY:
74500
show subpopulations
Gnomad4 AFR
AF:
0.000866
AC:
0.000866092
AN:
0.000866092
Gnomad4 AMR
AF:
0.00451
AC:
0.00451039
AN:
0.00451039
Gnomad4 ASJ
AF:
0.00375
AC:
0.0037464
AN:
0.0037464
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000828
AC:
0.000827815
AN:
0.000827815
Gnomad4 FIN
AF:
0.00151
AC:
0.00150517
AN:
0.00150517
Gnomad4 NFE
AF:
0.00516
AC:
0.00515964
AN:
0.00515964
Gnomad4 OTH
AF:
0.00236
AC:
0.00236295
AN:
0.00236295
Heterozygous variant carriers
0
24
47
71
94
118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00446
Hom.:
0
Bravo
AF:
0.00322
EpiCase
AF:
0.00420
EpiControl
AF:
0.00504

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STAT1: BP4, BS2 -

Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency Uncertain:1Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Mar 22, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

STAT1-related disorder Benign:1
Apr 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Immunodeficiency 31B;C3279990:Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome;C4013950:Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
15
DANN
Benign
0.80
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0017
dbscSNV1_RF
Benign
0.072
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45459703; hg19: chr2-191862937; API